ЮРіЯ-ФАРМ is a Ukrainian pharmaceutical group that is making its mark in the world. With 90% of its profits reinvested and a yearly target growth of 20%, this brand is on the rise. Each year, they introduce 20+ new medications and obtain 600+ registration certificates.

Operating in over 40 countries, they have a 25% export share. One of their recent achievements includes participating in the Inscience Conference 2023, where their R&D scientists shared their experience in developing innovative mRNA-based vaccine solutions. Another significant development is the inclusion of Reka-Med in the group, which will expand their activities in Central Asian countries.

Reka-Med will serve as a manufacturing site, ensuring the supply of high-quality parenteral medicines. Despite facing challenges during the war in Ukraine, ЮРіЯ-ФАРМ remained resilient, quickly restoring production and adapting to energy shortages. With a focus on research and development, they continue to bring exceptional pharmaceutical solutions to the market